Bio-Rad Laboratories Inc (STU:BUWA)
€ 344.3 4.8 (1.41%) Market Cap: 9.37 Bil Enterprise Value: 9.16 Bil PE Ratio: 0 PB Ratio: 1.39 GF Score: 75/100

Bio Rad Laboratories Inc at JPMorgan Healthcare Conference Transcript

Jan 13, 2020 / 07:00PM GMT
Release Date Price: €344
Tycho W. Peterson
JP Morgan Chase & Co, Research Division - Senior Analyst

We'll kick it off. I'm Tycho Peterson with Life Science team. It's my pleasure to introduce our next company Bio-Rad. We'll do a breakout right after in Sussex room. With that, let me turn it over to Norman.

Norman D. Schwartz
Bio-Rad Laboratories, Inc. - Chairman, CEO & President

Okay. Thanks, Tycho. Okay. The music stop. That must be me. Okay. Well, thank you all for joining us. We're going to take this opportunity to tell you a little bit about Bio-Rad, about our rich history, how we've contributed to science and health care, and where we've been investing, and of course, what we see for the future. So before we get started, caution you that we will be making forward-looking statements, which do carry with them inherent risks.

So for those of you who are new to Bio-Rad, we do have a rich history and a strong culture, but more important, I think we're well positioned for the future. Today, we serve these 2 markets: life science research and medical diagnostics. And

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot